Businesses for Sale and Investment Opportunities in New York

Eximso is a B2B cross-border e-commerce company located in Ernakulam, India. We started our operation in August of last year. During the period we learned what is the exact problem sellers and buyers face in a cross-border shipment. Finding genuine sellers and buyers is not an easy job. Even after that, the work is not going to be finished. We should deal with logistics, payment, customs clearance, etc. A procurement company helps industries get the right goods /services at the best price and a logistics company helps move goods from one place to another at the earliest. These two functions are correlated and one can’t stand alone. We Eximso came up here to make function both at the same time. We have a team of professionals with in-depth knowledge of sourcing and negotiating skills. Irrespective of the categories and volume of the materials, we do procurement and ship globally. Now customers can sell or buy goods as easily as in a local market through Eximso.

Unlike most other clinics, we want to find out what is causing the skin disease before treating it. The skin is the largest living organ in the human body, and most illnesses (such as autoimmune disease, which is on the rise owing to stress), allergies, or diseases present as symptoms in the skin. We at Organic Aesthetics London wish to assist you in looking at the issues from the inside out. Our monthly clientele ranges from 100 to 200 valued clients, and our treatments cost from GBP 500 to 1500. What distinguishes us is that each patient is treated by either a chemist or a plastic surgeon with a strong reputation.

We help business owners run profitable 3D printing micro factories under the Virtual Factories brand. By joining our 'glocalized' network, operators gain access to our customer marketplace, helping us 're-shore' manufacturing. Virtual Factories is building a network of local 3D printing micro-factories to replace inefficient supply chains by reshoring manufacturing to North America. These localized 3D printing micro-factories produce parts and products ordered online through our marketplace. Virtual Factories return manufacturing and money to local communities.

Kisikon has created a completely new approach towards health, beauty, and well-being in a 100% natural way with a 360 package. Our concept is unique in every aspect. We offer a melange of services that include oxygen sessions, cryo sessions, and nutrition counseling. It is a high-end service that has results. Kisikon™ is a part of the huge cosmetic industry business. Furthermore, it is the cherry on the cake of the beauty Bio-Tech industry. With fast growth through franchises, it has the prospect to become a leader. The c return on investment period is a comfortable 2.5 years whilst EBITDA starts from 40%. What makes Kisikon™ so unique? Kisikon ™ is a carefully combined melange of the best benefits deriving from scientific studies and medicine praxis from hyperbaric fields enriched with cryo stimulations and, optionally, supported by EFT (Electric Field Therapy stimulation). The secret key lies in special séances protocols accessible only in the franchise Kisikon ™. The HQ of Kisikon will also always take care that all franchise units will operate with high-end support from our specialist teams and maintain up-to-date knowledge in its industry.

• Established business with existing clients located in a high-traffic area in Franklin Square. • Professional medical spa offering a variety of services including facials, body contouring, microdermabrasion, chemical peels, cool sculpting, and laser treatments. • Have additional services such as a tattoo for permanent makeup. • Have 1500 square feet of space with parking in rear. • Beautiful buildout with reception area, 5 treatment rooms, waiting area, office, billing area and a full basement. • Potential for a new owner to take advantage of the existing customers and expand the business. • Highly sought-after industry in the area, with a potential to increase customer base and revenue. • Owner is taking care of the business for now with the help of part time staff.

- US International Beauty School started with a single goal in mind: to deliver world-class, high-quality beauty and cosmetics education in India, taught by skilled professionals and instructors. - With that in mind, we developed a world-class infrastructure with the assistance of our top-notch trainers. - We have 2 operational beauty school centers in and around Gurgaon. - Have 500+ active students enrolled in our courses ranging from short-term 15-day courses to long-term 2-year courses. - Tied up with well-known beauty studios such as Sephora, Colors Makeup Studio, and Geetanjali for placement of our graduates. - We not only produced a large number of graduates in a short period of time, but we also guaranteed that they were placed in jobs where they could use the skills we had taught them. - We are looking to expand our brand globally. The sales figures for our franchise format are conservative estimates based on the monthly sales of our current centers.

- We have five in-house scientific projects: 1) An exosome-based delivery system for the transport, delivery, and localization of therapeutic molecules within the skin tumor microenvironment to treat human skin cancer. 2) The development of a confocal virtual reality (VR) 3-dimensional (3-D) immersive system for the diagnosis and analyses of human skin cancer tumors. 3) A skin cancer patient blockchain whereby skin cancer patients can set up smart contracts & receive payment for the use of their data from drug companies, research institutes, medical device companies, etc. 4) The utilization of ML and AI to visualize and analyze the resultant data from skin cancer subjects for the benefit of skin cancer patients, their family, and their healthcare providers. 5) The development of an in vitro toxicology system that uses human umbilical cord- and placental- derived mesenchymal stem cells, and cell lineages that may be derived from these, to serve as a developmental toxicological tool to reduce the number of animals use in preclinical drug research. - The company also works with pharmaceutical and diagnostic companies, research institutes, CROs, and CDMOs to help them develop molecular bioassays and digital pathology products, and to visualize and analyze the resultant data via AI and ML for the benefit of patients, their family, and their healthcare providers. - Currently, we have 3 clients: Klotho Therapeutics Inc. (a biotechnology company in San Diego, CA, USA), Unger Medical PC (a hair restoration medical practice in NY, NY, USA), and Astrix Technology Group (a life sciences strategy, technology, and staffing services company based in Red Bank, NJ, USA). • Target Market: - The business is specialized in developing diagnostics and therapeutics for human basal cell carcinoma, squamous cell carcinoma, and melanoma. This skin cancer group comprises the most diagnosed cancers worldwide of all cancer types with over five million cases diagnosed each year. - The skin cancer therapeutics diagnostics and therapeutics products industry worldwide were worth $8.2 billion USD in 2019 and is projected to reach $15 billion by 2027. This represents a CAGR of 7.5%. - What share of the total skin cancer target market is realistic for us to obtain? A conservative estimate is that our company should be able to reach $150 million USD in annual revenues by the close of 2028. • Problem or Need: - The main project involves the development of a Skin Cancer Patient Data Blockchain. - Currently there is a serious problem concerning how oncology patients organize and share their medical data, how companies get access to this data, and a lack of return in value to the patients for sharing their personal data. The blockchain is designed to tackle and solve these problems. - The blockchain for skin cancer patients will be comprised of multiple decentralized nodes contributing data to a shared ledger where patients can set up smart contracts to share and control their data. - Skin cancer patients will be able to share their data with research institutions, drug companies, diagnostic companies, contract research organizations, client trials organizers, and other stakeholders. - Also, planning to launch a medium of exchange within the blockchain system to allow patients to be given money for participation in the sharing of their data with the mentioned company stakeholders. - Therefore, the company stakeholders that plan to utilize the patient’s data would provide revenues and income to support the operations of the blockchain. - For example, pharmaceutical companies would be important customers that the business would cultivate as users of the patient’s healthcare data. This is because pharma companies can use this blockchain to discover patients with the right profile for a skin cancer clinical trial, even if those patients were not actively searching to participate in a clinical trial for a product from which the pharma or diagnostics company might benefit. This should greatly streamline for the pharma company the time it takes to enroll the right patients into clinical trials and get them started. • Solution: - What is the core value proposition? For the company stakeholders in the skin cancer patient blockchain, the business is hoping to demonstrate that this blockchain technology will be a way to improve business outcomes through better efficiency, risk management, and security. - For these customers, this will enable them to maintain and capture new sources of profit. At the same time, company stakeholder participation will also grow the business as the integrator and host of the blockchain and result in significant profit growth for the company. • Team: The team is comprised of: - Founder, President, and CEO, a 100% full-time permanent employee has a Ph. D. in Cell and Molecular Biology from St. John’s University (New York, NY), a M. S. in Microbiology & Immunology from Long Island University, and a M. B. A. from Le Moyne College. In addition, he has 20 years of quality assurance and regulatory affairs experience at the Bristol-Myers Squibb Company, Charles Rivers Laboratories, and Vybion, Inc. This includes moving numerous human therapeutic products from R&D, through clinical trials, and into the marketplace via approval by the US FDA and worldwide regulatory bodies. In addition to the above experience, Joseph has an addition 18 year of experience in human therapeutics research and development and in the management of laboratory-based cell culture, toxicological, or bioassay projects within the biopharmaceuticals industry. However, he is a Senior Member of the food, drugs & cosmetics section of the American Society for Quality (ASQ), and a society member of The American Association for the Advancement of Science (AAAS). - The President of Hillberg Consulting is a part-time, non-permanent hourly contract employee of R&D department. She is an accomplished executive and board member with a reputation for delivering bottom-line profitability while building the infrastructure to support growth and success. She has served at Johnson & Johnson Ortho Clinical Diagnostics as VP of R&D, and as Chief Technology Officer at Carestream Health. Holly has a B. S. in Chemical Engineering from Michigan Technology University and a M. S. in Electrical Engineering from Rochester Institute of Technology. - Marketing Consultant - part-time, non-permanent hourly employee. He is a professional engineer and entrepreneurial executive with a focus on emerging technology solutions applied to real world problems. He has substantial experience in team building and in developing market strategies & partnerships. This includes over two decades of technology & networks business planning, development, & implementation. He has a Masters in Entrepreneurial Studies - MIT Sloan School of Management, and M. S. & B. S. in Engineering from Syracuse U. and Utica College. - Blockchain Development Technical Project Management Consultant - Part-time, non-permanent hourly employee that is a contractor from EffectiveSoft Corporation, San Diego, CA. She has eight years of experience as VP of Service Delivery and as the Head of Sales for enterprise level software solutions at Effective Soft Corp. She has a M. B. A. from The University of Manchester and a B. S. degree from Minsk State Linguistics U. – Legal Counsel - Part-time, non-permanent hourly contract employee. He holds the Juris Doctor from Boston College Law School, and B. A. in Political Science from Binghamton University. He is a Partner at Newman & Lickstein, with eight years of experience in representing technology companies and investors in licensing, IP development, real estate, mergers & acquisitions, and business litigation. - Demonstrating results to stakeholders will be the key to success. For skin cancer, there is a lot of data collected from various heterogeneous sources – pathology imaging data, genetic testing, surgery, drugs intervention, payer, and insurance information, etc. - Some companies are using a website or app to meet the social needs of patients to discuss their concerns with other patients or a few qualified physicians. No competitor is comprehensively focusing on skin cancer data & treatment to the level that we do. Possible competitors have thus not yet integrated the patient data, shared consent, and the patient monetization blocks together into a comprehensive and workable blockchain system for skin cancer patients, or for any segment of the oncology market, for that matter. - This team, on the other hand, has decades of experience in oncology research, the development of products and services for cancer patients, in oncology clinical biomedicine and in oncology marketing, and that makes the company well-equipped to solve the problems around skin cancer patient data acquisition, its organization, and its beneficial use for the patients and for their healthcare providers. For example, regarding the latter, the company also harnesses artificial intelligence (AI) and machine learning (ML) to extract relevant data from the patient’s database that will help healthcare providers to better understand the patient’s tumor and the tumor microenvironment (i. e. , tumor growth, cellular migration, blood supply to the tumor, subcellular trafficking, and tumor metastasis), drug efficacy (including drug penetration into the tumor, possible tumor shrinkage or tumor death, and drug toxicity, and side effects), or the immediate or long term results of surgical intervention. - When competitors enter this specific market, the business plans to stand out by utilizing a value-based strategy that clearly displays our brand and the above competitive advantage. • Traction: - Currently works with pharmaceutical and diagnostic companies, research institutes, and contract research development and manufacturing companies to help them obtain and organize their molecular bioassays and pathology data. We propose to utilize this traction and intercompany personal connections to gain and grow customers that will use and pay for patient data on the blockchain. - Also use social media & patient advocacy organization to recommend the blockchain to skin cancer patients so that we can grow the patient database. - The company is also a member of the Hyperledger Foundation Healthcare Special Interest Group. Hyperledger, as part of the Linux Foundation, provides technology leaders with a uniquely open and collaborative international community from which to develop, validate, and field enterprise-grade blockchain technology solutions. It is the mandate of the Hyperledger Healthcare Special Interest Group (HC-SIG) to represent healthcare professionals and technologists, to globally unite these individuals, and to advance the state of the healthcare industry through the implementation of technology solutions using blockchain technologies in general, and the umbrella of Hyperledger frameworks and toolsets specifically. • Revenue Model: - Within the ecosystem surrounding the above patients, who would buy/lease the skin cancer blockchain services that the company wishes to market? In this blockchain system, individuals will be allowed to store and monetize their own health data including blood test results, medical history, genetic profile, skin photographs, pathology images and other sensitive information. - In the healthcare marketplace, cancer patients would be paid in stablecoin currency to lease their individual data to companies for a certain amount of time. - Pharmaceutical (pharma) companies would be important customers that the company would cultivate as users of the patient’s permitted healthcare data. - Blockchain can help pharma companies discover patients with the right profile for a clinical trial, even if those patients were not actively searching to participate in a clinical trial for a product from which the pharma or diagnostics company might benefit. - According to Milind Kamkolkar, chief data officer at Sanofi, patients could be prompted based on their data to join a clinical trial, thereby also accelerating the process and accuracy of trial recruitment. Using this blockchain if a person declines, no personal information will be shared, and the person's identity will remain private. If the person agrees, the overall process will move faster by abolishing the need for intermediaries. - For pharma companies, better inclusion in clinical trials and better reproducibility for studies can reduce the time and money needed to develop new drugs. - Besides pharma companies, research institutes will be willing to pay for the data from skin cancer patients, and the introduction of our blockchain-based data ecosystem may help ensure that the individuals take control over their data and companies and research institutions may acquire data more freely after the latter have obtained consent from individual patients. - How are the products and services going to generate revenue? The most straightforward way to generate revenue is to have the blockchain client customers pay for the products and services that exceed by a large margin what it costs to develop and operate the blockchain (a cost-plus strategy). - When competitors enter this specific market, plan to stand out by utilizing a value-based strategy that clearly displays the brand and competitive advantage. • Market Projections: - What share of the total skin cancer blockchain target market can we estimate is realistic for to obtain? The global skin cancer blockchain customer market size stood at USD 8.19 billion in 2019 and is projected to reach USD 14.55 billion by 2027, exhibiting a CAGR of 7.5% during the forecast period. A conservative estimate is that the company should be able to reach $150 million in annual revenues in 4 years. - These financial projections would be possible because of the company participating and partnering with individuals and companies within the oncology community to create superior value for the products and services. - Over the next 4 years, the company anticipates receiving funding from investors, and revenues from pharmaceutical companies and research institute customers. - However, expenditure are also expected to increase. Expenses incurred will be for the development of products and services, and for personnel, equipment, supplies, business development & marketing. • Competition: - We have identified Nebula Genomics and Longenesis as competitors. These two leading firms in artificial intelligence and blockchain technology for healthcare, are developing a platform for the storage and exchange of genomic data. - Nebula Genomics is a San Francisco-based biotechnical company that uses blockchain to “build a marketplace” for clinical genetics data. - Longenesis is a Hong Kong-based partnership between Insilico Medicine and the Bitfury Group, which makes blockchain platforms for the exchange of health data. - The above companies will reportedly apply artificial intelligence and blockchain technology to develop a platform for individuals and large data providers to store, manage, exchange, and profit from genomic and other types of clinical data. To automate data acquisition, the project developed by both Nebula Genomics and Longenesis will utilize smart contracts. - Unlike the Nebula Genomics and Longenesis blockchains, this blockchain project will be focused on oncology patients and the ecosystem around them rather than on a multitude of disease sectors. - In addition to Nebula Genomics and Longenesis, the U. S. -based life science research marketplace, Scientist. com, has revealed the development of a pharmaceuticals blockchain platform. This latter blockchain-powered platform is reportedly designed to track and protect pharmaceutical data. Thus, the Scientist. com DataSmart TM platform enables pharmaceutical and biotech companies to demonstrate that critical supplier information and important research data has not been tampered with and remains unaltered before submission to regulators such as the FDA and the EMEA. - However, the above platforms do not adequately address the pressing concerns of cancer patients regarding the control and sharing of their personal data. Competitive Advantage: • Strategy. Specifically for oncology blockchain products, the major company players that may join our blockchain to gain access to data from skin cancer patients include: Almirall S. A. Amgen, Inc. Boehringer Ingelheim GmbH. Bristol-Myers Squibb Company. Eli Lilly and Company. Elekta AB. F. Hoffmann-La Roche Ltd. GlaxoSmithKline plc. Merck & Co. , Inc. Mylan NV. Novartis AG. Pfizer. Regeneron. Sanofi. Sun Pharmaceutical Industries Ltd. Varian Medical Systems, Inc. Sensus Healthcare. ICAD, Inc. Accuray, Inc.

- We are a fashion designing firm from Israel and specialize in modern modest and stylish women's fashion and beauty. - Our business has been operational for the past two years and is in a growth phase with a lot of future potential. We are the creators of the best looking and quality press on nails. Our vision is to make all women in the world to stop wasting their time, money and health in a saloon without sacrificing the quality gel nail look. Our gel nails are reusable and come with our exclusive glue remover so that women of all ages can play around with their outfits and mix and match nails with their fashion. We see our nails being sold and loved by women all over the world. - We wish to connect with like-minded people who have the same vision as ours and want to work together with them. - The sales and profit margin are achievable.

Fast Review is a solution for upgrading a business's online reputation. Fast Review helps to boost a business's popularity, influence consumer decisions, strengthen a company's credibility, and ultimately increase sales. Brands take advantage of the opportunities provided by Fast Review to be noticed as exceptional. We are company headquartered in Zagreb and wish to expand to various regions in Europe.

- We are a growing Ayurvedic herbal health supplement company committed to increase access to high quality immunity booster products at affordable price. - We are the manufacturers of health booster products in the form of dried powder from the 100% natural herbs and cereals. - The products are being produced in an in-house, facilities and our FSSAI auditor’s report is A+ grade self explaining itself. - We offer these products at throat cut price with a guaranteed purity. We do not use preservatives and chemical for the durability of the product. - Our mission is to initially start with third party retailers but very soon we will start our own chain of retail shops across India.

We are an asset leasing platform where one can invest in assets leased to corporates. We work with well-funded start-ups and profitable SMEs who use leasing instead of debt. Leasing allows them to manage cashflows, expand nimbly and leverage healthily. Our investors earn returns through monthly rents with an assured buyback. The assets we lease out are tangible and we mostly lease out to corporates. We have screened 1,600 companies out of which we have listed 40 companies on our platform. The most in-demand sector for our investors is logistics and IT equipment.

Aim Global Business Corp is headquartered in Dubai, Silicon Oasis, a picturesque city. Located in the United Arab Emirates our mission is to provide the customer with whatever type of needs they may have in setting up their business and fulfilling their business needs. We offer a broad spectrum of services including office rental services, business licenses, company registration services, immigration services, and other value-added services. We have excellent customer service to encourage client retention and expeditious business. Since this is a service-based company, our operating expenses are low. This is a reason for a high operating profit margin. The financials mentioned in the profile are based on our existing outlets.

We Mapkit Solutions Private Limited is a pioneering manufacturer in the field of digital technology, specializing in the production of digital information kiosk, digital signage, and customized digital kiosk solutions, complemented by a suite of top-tier software services. Established with a commitment to innovation and excellence, Mapkit Solutions has emerged as a trusted leader in the digital display industry. With a passion for transforming the way information is presented and accessed, Mapkit Solutions designs and manufactures cutting-edge kiosk solutions that cater to a diverse range of industries and applications. These solutions seamlessly integrate hardware and software, offering a dynamic and interactive platform for businesses and organizations to engage with their audiences effectively. Driven by a customer-centric approach, Mapkit Solutions places a strong emphasis on customization, ensuring that each digital kiosk aligns perfectly with the unique needs and branding of its clients. The company's team of experts is dedicated to delivering tailor-made solutions that empower clients to communicate, inform, and engage with their target audience efficiently. In addition to its hardware offerings, Mapkit Solutions extends its services with a comprehensive software suite, which enhances the functionality and utility of their digital kiosk solutions. This synergy of hardware and software expertise sets Mapkit Solutions apart, making them an industry leader in delivering end-to-end digital display solutions. Whether it's enhancing customer experiences, streamlining information dissemination, or creating engaging interactive displays, Mapkit Solutions Private Limited is at the forefront of the digital revolution, empowering businesses and organizations to harness the power of technology for communication and engagement. We have a customer base of 5000. Having ISO certification.

Chai NGO (Nashedi Gang Organisation) is a novel franchise model in India which focuses on the country's most flavour drink - The Chai. While you visit any of our restaurant joints you will not only smell the aroma of a variety of flavors from different gardens of India but also feel the warmth of our hospitality which is our secret ingredient in all our preparations. Nashedi Gang Organisation was created to cater to all those who want to connect to their friends, families, and loved ones, be it a celebration or a meeting with your crush or hanging out, whatever it may be, the customer will surely get addiction of goodness' that is being served as a complimentary dish with every order. We develop long-term relationships in a joined effort to realize mutual growth. We are a small, highly successful team of professionals dedicated to finding our golden egg, and that is what makes our brand and product unique.